Optimized and Personalized Trans-cranial Brain Stimulation in Partial Refractory Epilepsies
RecruitingNCT06212609Phase: NAStarted 2023-12-01
Summary
Epilepsy is one of the most common neurological diseases, affecting between 0.5% and 1% of the general population. Therefore, new diagnostic and treatment methods are having a big impact on society. E
Eligibility
Sex
ALL
Min Age
1 Year
Max Age
18 Years
Locations
CHU AmiensAmiens, France
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06212609